Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PEGASUS-2: Scaling a Decision Aid on Prenatal Screening for Trisomy 21, 18 and 13: A Stepped Wedge Cluster Randomized Trial

NCT05859139 is registered in ClinicalTrials.gov with CHU de Quebec-Universite Laval as lead sponsor.

NCT NCT05859139
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05859139 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PEGASUS-2: Scaling a Decision Aid on Prenatal Screening for Trisomy 21, 18 and 13: A Stepped Wedge Cluster Randomized Trial
Lead sponsor
CHU de Quebec-Universite Laval
Phase
Not applicable
Overall status
Completed
Start date
February 1, 2023
Completion date
July 31, 2024
Enrollment
887 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

decision aid